SpringWorks Therapeutics, Inc. financial data

Symbol
SWTX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
100 Washington Boulevard, Stamford, CT
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 676 % -40.5%
Quick Ratio 9.5 %
Debt-to-equity 14.3 % -0.07%
Return On Assets -42.2 % +24.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 74.4M shares +18.9%
Common Stock, Shares, Outstanding 74.3M shares +18.8%
Entity Public Float 1.6B USD +76.6%
Common Stock, Value, Issued 7K USD +16.7%
Weighted Average Number of Shares Outstanding, Basic 74.3M shares +18.8%
Weighted Average Number of Shares Outstanding, Diluted 74.3M shares +18.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 49.3M USD
Research and Development Expense 184M USD +27.1%
General and Administrative Expense 178M USD +47.9%
Costs and Expenses 115M USD +47.9%
Operating Income (Loss) -295M USD +8.59%
Nonoperating Income (Expense) 26.5M USD +21%
Net Income (Loss) Attributable to Parent -275M USD +9.77%
Earnings Per Share, Basic -3.89 USD/shares +43.3%
Earnings Per Share, Diluted -3.89 USD/shares +43.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 84.5M USD -14.6%
Marketable Securities, Current 525M USD +94.7%
Cash, Cash Equivalents, and Short-term Investments 498M USD +17.9%
Accounts Receivable, after Allowance for Credit Loss, Current 33M USD
Inventory, Net 9.83M USD
Assets, Current 435M USD +0.63%
Property, Plant and Equipment, Net 19.3M USD -7.59%
Operating Lease, Right-of-Use Asset 6.03M USD -6.79%
Other Assets, Noncurrent 20.7M USD +494%
Assets 609M USD +30.2%
Accounts Payable, Current 9.65M USD +74.1%
Employee-related Liabilities, Current 20.3M USD +19.2%
Accrued Liabilities, Current 59.7M USD +48.1%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 70.6M USD +40.4%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 5.68M USD -7.88%
Other Liabilities, Noncurrent 14.7M USD +11091%
Liabilities 76.3M USD +4.87%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.61M USD
Retained Earnings (Accumulated Deficit) -1.08B USD -34.4%
Stockholders' Equity Attributable to Parent 533M USD +34.9%
Liabilities and Equity 609M USD +30.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -78.9M USD -27.7%
Net Cash Provided by (Used in) Financing Activities -552K USD +70.1%
Net Cash Provided by (Used in) Investing Activities 21.5M USD -78.2%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 74.7M shares +19.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -58M USD -266%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 85.1M USD -14.5%
Deferred Tax Assets, Valuation Allowance 227M USD +44%
Deferred Tax Assets, Gross 230M USD +44.6%
Operating Lease, Liability 7.06M USD +34.4%
Depreciation 253K USD +134%
Payments to Acquire Property, Plant, and Equipment 577K USD -80.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -273M USD +10%
Lessee, Operating Lease, Liability, to be Paid 8.03M USD +33.7%
Property, Plant and Equipment, Gross 20.6M USD +39%
Operating Lease, Liability, Current 1.23M USD +5.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2M USD +73.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.48M USD +88.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +47.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 970K USD +29%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2M USD +69.1%
Deferred Tax Assets, Operating Loss Carryforwards 121M USD +30.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.9M USD +57%
Additional Paid in Capital 1.62B USD +34.9%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 729K USD +188%
Share-based Payment Arrangement, Expense 108M USD +21.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%